Market Closed -
Nyse
04:00:01 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
110.5
USD
|
-0.61%
|
|
-0.10%
|
+6.55%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
37,683
|
30,869
|
40,915
|
36,601
|
37,470
|
39,712
|
-
|
-
|
Enterprise Value (EV)
1 |
51,636
|
44,709
|
55,446
|
48,505
|
46,453
|
51,118
|
51,118
|
51,193
|
P/E ratio
|
9.27
x
|
-78.1
x
|
5.55
x
|
-25.3
x
|
15.4
x
|
8.61
x
|
8.09
x
|
7.48
x
|
Yield
|
4.27%
|
5.64%
|
4.25%
|
4.83%
|
4.82%
|
4.66%
|
4.75%
|
4.78%
|
Capitalization / Revenue
|
0.65
x
|
0.57
x
|
0.68
x
|
0.61
x
|
0.74
x
|
0.72
x
|
0.7
x
|
0.67
x
|
EV / Revenue
|
0.89
x
|
0.83
x
|
0.93
x
|
0.81
x
|
0.91
x
|
0.92
x
|
0.9
x
|
0.86
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
5.65
x
|
-
|
-
|
13.1
x
|
10.9
x
|
-
|
FCF Yield
|
-
|
-
|
17.7%
|
-
|
-
|
7.64%
|
9.19%
|
-
|
Price to Book
|
0.6
x
|
0.47
x
|
0.67
x
|
2.27
x
|
1.35
x
|
1.31
x
|
1.2
x
|
1.08
x
|
Nbr of stocks (in thousands)
|
402,000
|
395,400
|
378,000
|
368,000
|
361,300
|
359,380
|
-
|
-
|
Reference price
2 |
93.74
|
78.07
|
108.2
|
99.46
|
103.7
|
110.5
|
110.5
|
110.5
|
Announcement Date
|
2/4/20
|
2/4/21
|
2/3/22
|
2/7/23
|
2/6/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
58,132
|
54,149
|
59,781
|
60,050
|
50,894
|
55,382
|
56,675
|
59,249
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
7,638
|
6,714
|
8,775
|
6,212
|
7,282
|
8,151
|
7,136
|
-
|
Operating Margin
|
13.14%
|
12.4%
|
14.68%
|
10.34%
|
14.31%
|
14.72%
|
12.59%
|
-
|
Earnings before Tax (EBT)
1 |
5,085
|
-323
|
9,381
|
-1,776
|
3,072
|
6,047
|
5,790
|
6,182
|
Net income
1 |
4,186
|
-374
|
7,724
|
-1,438
|
2,488
|
4,620
|
4,861
|
5,373
|
Net margin
|
7.2%
|
-0.69%
|
12.92%
|
-2.39%
|
4.89%
|
8.34%
|
8.58%
|
9.07%
|
EPS
2 |
10.11
|
-1.000
|
19.51
|
-3.930
|
6.740
|
12.83
|
13.65
|
14.77
|
Free Cash Flow
1 |
-
|
-
|
9,812
|
-
|
-
|
3,908
|
4,699
|
-
|
FCF margin
|
-
|
-
|
16.41%
|
-
|
-
|
7.06%
|
8.29%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
127.03%
|
-
|
-
|
84.57%
|
96.67%
|
-
|
Dividend per Share
2 |
4.000
|
4.400
|
4.600
|
4.800
|
5.000
|
5.154
|
5.254
|
5.278
|
Announcement Date
|
2/4/20
|
2/4/21
|
2/3/22
|
2/7/23
|
2/6/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
12,867
|
13,744
|
13,657
|
13,774
|
21,611
|
11,008
|
15,104
|
12,644
|
12,206
|
13,020
|
14,496
|
13,362
|
13,682
|
13,860
|
13,822
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
1,947
|
1,930
|
1,273
|
1,433
|
1,576
|
1,707
|
1,853
|
2,023
|
-
|
1,873
|
2,079
|
2,125
|
2,074
|
-
|
Operating Margin
|
-
|
14.17%
|
14.13%
|
9.24%
|
6.63%
|
14.32%
|
11.3%
|
14.66%
|
16.57%
|
-
|
12.92%
|
15.56%
|
15.53%
|
14.96%
|
-
|
Earnings before Tax (EBT)
|
1,806
|
1,388
|
-115
|
-511
|
-437
|
-713
|
1,847
|
-
|
-1,058
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
1,530
|
1,208
|
-31
|
-565
|
-284
|
-558
|
1,462
|
511
|
-802
|
1,317
|
1,041
|
1,187
|
1,245
|
1,226
|
1,233
|
Net margin
|
11.89%
|
8.79%
|
-0.23%
|
-4.1%
|
-1.31%
|
-5.07%
|
9.68%
|
4.04%
|
-6.57%
|
10.12%
|
7.18%
|
8.88%
|
9.1%
|
8.84%
|
8.92%
|
EPS
2 |
3.900
|
3.130
|
-0.1000
|
-1.530
|
-0.7800
|
-1.530
|
3.930
|
1.380
|
-2.230
|
3.610
|
2.884
|
3.265
|
3.381
|
3.311
|
3.438
|
Dividend per Share
2 |
1.150
|
1.150
|
1.200
|
1.200
|
1.200
|
1.200
|
1.250
|
1.250
|
1.250
|
1.250
|
1.300
|
1.300
|
1.300
|
1.300
|
1.333
|
Announcement Date
|
11/2/21
|
2/3/22
|
5/3/22
|
8/2/22
|
11/1/22
|
2/7/23
|
5/2/23
|
8/1/23
|
11/1/23
|
2/6/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
13,953
|
13,840
|
14,531
|
11,904
|
8,983
|
11,406
|
11,406
|
11,481
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
9,812
|
-
|
-
|
3,908
|
4,699
|
-
|
ROE (net income / shareholders' equity)
|
12.1%
|
6.3%
|
8.93%
|
9.2%
|
12.2%
|
14.1%
|
13.7%
|
13.2%
|
ROA (Net income/ Total Assets)
|
0.57%
|
0.45%
|
0.61%
|
0.44%
|
0.61%
|
0.9%
|
0.9%
|
0.9%
|
Assets
1 |
739,445
|
-83,669
|
1,256,752
|
-325,782
|
409,278
|
513,374
|
540,090
|
596,997
|
Book Value Per Share
2 |
156.0
|
168.0
|
161.0
|
43.80
|
76.80
|
84.60
|
92.10
|
102.0
|
Cash Flow per Share
|
-
|
21.10
|
25.20
|
13.80
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
-
|
-
|
-
|
-
|
3,993
|
3,993
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
7.21%
|
7.05%
|
-
|
Announcement Date
|
2/4/20
|
2/4/21
|
2/3/22
|
2/7/23
|
2/6/24
|
-
|
-
|
-
|
Last Close Price
110.5
USD Average target price
113.7
USD Spread / Average Target +2.89% Consensus |
1st Jan change
|
Capi.
|
---|
| +6.55% | 39.71B | | +6.49% | 50.92B | | +1.35% | 48.11B | | +9.53% | 42.2B | | +19.34% | 37.78B | | +2.84% | 30.07B | | -7.77% | 27.56B | | -18.42% | 24.71B | | +6.89% | 21.99B | | +20.69% | 21.68B |
Other Life & Health Insurance
|